Alternatives to Longevity Bio

AI-guided drug discovery platform for tissue-targeted medicines.

Developing novel therapeutics targeting dysfunctional DNA packaging for diseases like cancer.

Clinical-stage biopharma developing precisely designed cancer therapeutics using a proprietary cell-free protein synthesis platform.

Biopharmaceutical company developing therapies for neurodegenerative diseases, focusing on crossing the blood-brain barrier.

Cradle Bio B.V. is a Dutch, Swiss biotechnology company that develops software using machine learning for protein engineering. It was founded in 2021 and is base

Developing engineered biologics to harness the immune system for disease treatment.

Biopharmaceutical company developing novel therapeutics for cancer and other diseases using chemoproteomics and covalent chemistry.

Developing novel therapeutics by understanding the complex interplay of biological systems.

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Biotechnology company developing immuno-neurology therapies for neurodegenerative diseases.

A clinical-stage oncology company developing DNA interference (DNAi) based cancer therapies.

Irish BioTech startup Aerska raises €32 million to enable loved ones to live longer.

Developing novel therapeutics for rare genetic diseases with a focus on protein degradation.

Developing novel therapeutic antibodies for challenging diseases.

Develops novel protein engineering and directed evolution technologies for therapeutic discovery.

A biotechnology company focused on extending healthy human lifespan by targeting the biological causes of aging.

Developing novel therapeutics for challenging diseases using advanced biological insights.

Biotech company focused on developing therapies to extend human healthspan and lifespan.

Develops and manufactures biologics for therapeutic applications.

Biotechnology company focused on developing therapies to extend human healthspan and reverse aging.

Develops long-acting implantable and injectable therapies for opioid addiction and chronic pain.

Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

A clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.

BreezeBio is a genetic medicine company developing a pipeline of precision therapeutics.

Biotechnology company specializing in antibody discovery and protein engineering for therapeutic applications.

Omega Therapeutics is developing a new class of programmable medicines called Epigenomic Controllers.

Biotechnology company advancing novel therapeutics using its proprietary LEADS drug discovery platform.

A global biotechnology company discovering, developing, manufacturing, and delivering innovative human therapeutics.

Developing novel therapeutics for rare and underserved diseases.

Clinical-stage biopharmaceutical company developing next-generation therapies for obesity and cardiometabolic diseases.

Engineering scalable gene therapies for broader patient populations.

AI-powered antibody discovery platform.

Developing novel therapies to reverse aging and extend lifespan.

Fueling a 21st-century renaissance by increasing the ambition of philanthropists, scientists, and innovators.

Developing epigenetic reprogramming drugs for age restoration.

Leveraging the adaptive immune system to diagnose and treat disease.

BioAge Labs is a biotechnology company focused on developing therapies to extend human healthspan and lifespan.

Advancing scalable microbiome-based therapeutics for severe and chronic diseases.

Scalable, one-time curative in-vivo gene editing therapies.

Global leader in enzymatic therapeutics for non-surgical tissue repair, replacing existing standards of care.

A global oncology company developing and commercializing innovative cancer treatments.

A commercial-stage immunotherapy company developing novel treatments for cancer and infectious diseases.

AI-powered platform for understanding disease biology and accelerating drug discovery.

Biotechnology company developing novel therapeutics to promote healthy longevity by understanding aging pathways.

Phenomics-driven AI company translating disease biology into precision medicine discoveries.

Engineering-driven DNA design platform to overcome biological barriers in genetic medicines.

Clinical-stage biotech company developing transformative cytokine therapies.

Synthace provides a no-code cloud platform for life sciences R&D, enabling scientists to automate experimentation and insight sharing.

AI-driven drug discovery platform for rapid development of novel therapeutics.

Computational protein design company creating novel enzymes and proteins using AI and physics-based modeling.

Developing disease-responsive advanced therapies through programmable gene control technology.

AI-powered biotechnology company developing RNA therapeutics for genetic diseases.

Mapping cell-cell communication at scale in human tissue.

AI-driven drug discovery company developing novel medicines for unmet patient needs.

Biotech startup leveraging bat biology for novel therapeutics in immunology and cardiometabolic diseases.

Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.

Developing novel protein engineering tools for advanced biomanufacturing and therapeutics.

MyBiotics Pharma develops innovative microbiome-based pharmabiotics and drugs using proprietary bacterial mixes and efficient delivery technologies.

ImCheck Therapeutics is a clinical-stage immuno-oncology company developing novel antibody therapies.